Femasys (FEMY) announces a partnership with Carolinas Fertility Institute. Carolinas Fertility Institute will provide the Company’s FemaSeed intratubal insemination product as an infertility treatment option to patients throughout its network in North Carolina.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FEMY:
- Femasys Announces Public Offering and Private Placement
- Femasys prices 3.6M shares at 85c in underwritten public offering
- Femasys announces common stock offering, no amount given
- Femasys Receives Nasdaq Delisting Notice for Low Market Value
- Femasys price target lowered to $6 from $10 at JonesResearch